lamotrigine has been researched along with Asymmetric Diabetic Proximal Motor Neuropathy in 7 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Patients (n=360 per study) with painful diabetic neuropathy were randomized to receive lamotrigine 200, 300, or 400 mg daily or placebo during the 19-week treatment phase, including a 7-week dose-escalation phase and a 12-week, fixed-dose maintenance phase." | 2.73 | Lamotrigine for treatment of pain associated with diabetic neuropathy: results of two randomized, double-blind, placebo-controlled studies. ( Blum, D; Corder, C; Grainger, J; Kirby, L; Quessy, S; Safirstein, B; Silver, M; Tuchman, M; Vinik, AI; White, J; Wilks, K, 2007) |
| " Assessment for pain relief, overall improvement and adverse events were carried out." | 2.73 | Randomized double-blind study comparing the efficacy and safety of lamotrigine and amitriptyline in painful diabetic neuropathy. ( Bhansali, A; Hota, D; Jose, VM; Pandhi, P, 2007) |
| "Lamotrigine is a sodium channel blocker that inhibits the neuronal release of glutamate." | 1.30 | Effects of intrathecally administered lamotrigine, a glutamate release inhibitor, on short- and long-term models of hyperalgesia in rats. ( Klamt, JG, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 6 (85.71) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hong, HB | 1 |
| Xu, RJ | 1 |
| Maeda, K | 1 |
| Yasuda, H | 1 |
| Vinik, AI | 1 |
| Tuchman, M | 1 |
| Safirstein, B | 1 |
| Corder, C | 1 |
| Kirby, L | 1 |
| Wilks, K | 1 |
| Quessy, S | 1 |
| Blum, D | 1 |
| Grainger, J | 1 |
| White, J | 1 |
| Silver, M | 1 |
| Jose, VM | 1 |
| Bhansali, A | 1 |
| Hota, D | 1 |
| Pandhi, P | 1 |
| Klamt, JG | 1 |
| McCleane, GJ | 1 |
| Eisenberg, E | 1 |
| Lurie, Y | 1 |
| Braker, C | 1 |
| Daoud, D | 1 |
| Ishay, A | 1 |
3 reviews available for lamotrigine and Asymmetric Diabetic Proximal Motor Neuropathy
| Article | Year |
|---|---|
[Progress on painful diabetic peripheral neuropathy treated by integrative medicine].
Topics: Amines; Amitriptyline; Analgesics; Animals; Antidepressive Agents, Tricyclic; Blood Glucose; Cyclohe | 2005 |
[Symptomatic treatment of painful diabetic neuropathy].
Topics: Amines; Anti-Asthmatic Agents; Anticonvulsants; Antidepressive Agents; Antitussive Agents; Cyclohexa | 2005 |
Lamotrigine in the management of neuropathic pain: a review of the literature.
Topics: Analgesics; Diabetic Neuropathies; Humans; Lamotrigine; Triazines; Trigeminal Neuralgia | 2000 |
3 trials available for lamotrigine and Asymmetric Diabetic Proximal Motor Neuropathy
| Article | Year |
|---|---|
Lamotrigine for treatment of pain associated with diabetic neuropathy: results of two randomized, double-blind, placebo-controlled studies.
Topics: Diabetic Neuropathies; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Lamotr | 2007 |
Randomized double-blind study comparing the efficacy and safety of lamotrigine and amitriptyline in painful diabetic neuropathy.
Topics: Adolescent; Adult; Aged; Algorithms; Amitriptyline; Analgesics, Non-Narcotic; Calcium Channel Blocke | 2007 |
Lamotrigine reduces painful diabetic neuropathy: a randomized, controlled study.
Topics: Diabetic Neuropathies; Female; Humans; Lamotrigine; Male; Middle Aged; Pain Measurement; Triazines | 2001 |
1 other study available for lamotrigine and Asymmetric Diabetic Proximal Motor Neuropathy
| Article | Year |
|---|---|
Effects of intrathecally administered lamotrigine, a glutamate release inhibitor, on short- and long-term models of hyperalgesia in rats.
Topics: Analgesics; Animals; Diabetic Neuropathies; Dinoprostone; Disease Models, Animal; Dose-Response Rela | 1998 |